![Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News](https://beta.ctvnews.ca/national/health/2021/10/7/1_5615048/_jcr_content/root/responsivegrid/image.coreimg.jpg)
Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News
![Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire](https://mms.businesswire.com/media/20200429005090/en/713670/23/teva_RGB_JPEG.jpg)
Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire
![Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/01/shutterstock_1424969885.jpg.optimal.jpg)
Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions
Teva Pharmaceutical Industries Ltd. - On Thursday May 12, Doug Sommerville General Manager Teva Canada, John Jacobs GM for Teva Canada Innovation, Ben Gray VP, General Counsel, Bennett Lee and Houri Ohan
![Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider](https://mma.prnewswire.com/media/657121/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of__ACT_M.jpg)